AVEO Pharmaceuticals, Inc. to Present at Upcoming Oncology Medical Meetings and Investment Conference

Show Health and Fitness Publications

Fri, October 8, 2010

[ Fri, Oct 08th 2010 ] - Market Wire

Apricus Bio Highlighted in Investment Newsletter

[ Fri, Oct 08th 2010 ] - Market Wire

Il presidente e fondatore di BioVitas Capital a" .. risultati positivi della fase IIa di plecanatide

[ Fri, Oct 08th 2010 ] - Market Wire

Emergent BioSolutions Launches Singapore Operations

[ Fri, Oct 08th 2010 ] - Market Wire

Cytori Therapeutics Prices Public Offering of Common Stock

[ Fri, Oct 08th 2010 ] - Market Wire

???????,LifeCella" Stratticea" ??????????????????

Thu, October 7, 2010

[ Thu, Oct 07th 2010 ] - Market Wire

Alexion Pharmaceuticals to Report Third Quarter Results on Thursday, October 21, 2010

[ Thu, Oct 07th 2010 ] - Market Wire

ImmunoCellular to Present at PrecisionIR Virtual Biotech, Healthcare & Pharma Conference

[ Thu, Oct 07th 2010 ] - Market Wire

45 prezentacji podczas 26. Kongresu Europejskiego .. ania Stwardnienia Rozsianego; Biogen Idec liderem

[ Thu, Oct 07th 2010 ] - Market Wire

Ligand to Divest Combinatorial Compound Library and Screening Technology for $1.8 Million

[ Thu, Oct 07th 2010 ] - Market Wire

Spectranetics Announces Retirement of Chairman and CEO Emile J. Geisenheimer

[ Thu, Oct 07th 2010 ] - Market Wire

Targacept Announces Top-Line Results of Phase 2 T .. h ADHD and Provides Update on Status of AZD1446 D

[ Thu, Oct 07th 2010 ] - Market Wire

Biogen Idec mostra liderana global em esclerose m .. taes de dados no 26 Congresso do Comit Europeu pa

[ Thu, Oct 07th 2010 ] - Market Wire

Con oltre 45 presentazioni di dati in occasione d .. o europeo per il trattamento e la ricerca sulla s

[ Thu, Oct 07th 2010 ] - Market Wire

Biogen Idec pone de manifiesto su liderazgo a niv .. a la esclerosis mltiple, con ms de 45 presentaci

[ Thu, Oct 07th 2010 ] - Market Wire

[ Thu, Oct 07th 2010 ] - Market Wire

Kindred Healthcare Appoints Jeffrey P. Winter as President of Its Hospital Division

[ Thu, Oct 07th 2010 ] - Market Wire

Affymax® Announces Decision in Arbitration Against JNJ

Wed, October 6, 2010

[ Wed, Oct 06th 2010 ] - Market Wire

Teva to Present New Data on Copaxone® and Laquinimod at the 26th Annual ECTRIMS Congress

[ Wed, Oct 06th 2010 ] - Market Wire

Synergy Pharmaceuticals Announces Positive Phase .. ts with Plecanatide to Treat Chronic Constipation

[ Wed, Oct 06th 2010 ] - Market Wire

Synergy Pharmaceuticals maakt positieve resultate .. erzoek naar het gebruik van plecanatide ter behan

[ Wed, Oct 06th 2010 ] - Market Wire

Aetna to Announce Third Quarter 2010 Results

[ Wed, Oct 06th 2010 ] - Market Wire

Insight Imaging Enters into Agreement to Sell Seven Imaging Centers

[ Wed, Oct 06th 2010 ] - Market Wire

DaVita Inc. Announces Pricing of $1.55 Billion Senior Notes

[ Wed, Oct 06th 2010 ] - Market Wire

Furiex Pharmaceuticals Announces Third Quarter 2010 Earnings Release, Webcast and Conference Call

[ Wed, Oct 06th 2010 ] - Market Wire

BELLUS HEALTH ANNOUNCES APPOINTMENT OF MARTIN TOLAR, M.D., Ph.D. TO ITS BOARD OF DIRECTORS

[ Wed, Oct 06th 2010 ] - Market Wire

Aetna Continues Efforts to Improve Access to Quality Care in the Middle East

[ Wed, Oct 06th 2010 ] - Market Wire

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 27, 2010

[ Wed, Oct 06th 2010 ] - Market Wire

Levi & Korsinsky, LLP Announces Class Action Laws .. Pharmaceuticals, Inc. and Its Board of Directors

[ Wed, Oct 06th 2010 ] - Market Wire

Medtronic Announces New Curette for Treatment of Vertebral Compression Fractures

Tue, October 5, 2010

[ Tue, Oct 05th 2010 ] - Market Wire

Synergetics USA to Webcast Presentation at Craig-Hallum Capital Group 2010 Alpha Select Conference

[ Tue, Oct 05th 2010 ] - Market Wire

The Briscoe Law Firm Investigates Johnson & Johns .. for Possible Breaches of Fiduciary Duties by its

[ Tue, Oct 05th 2010 ] - Market Wire

International Stem Cell Corporation and Insight B .. dian Affiliate to Develop Stem Cell-Based Eye Car

[ Tue, Oct 05th 2010 ] - Market Wire

Apricus Bio Closes Securities Offering, Raising over $9.3 Million

[ Tue, Oct 05th 2010 ] - Market Wire

LifeCell Strattice Reconstructive Tissue Matrix v .. complexe buikbreuken volgens belangrijk onderzoek

[ Tue, Oct 05th 2010 ] - Market Wire

Celgene Prices $1.25 Billion of Senior Unsecured Notes

[ Tue, Oct 05th 2010 ] - Market Wire

Bond Labs Expands Retail Presence of Resurrectiona" in Minneapolis

[ Tue, Oct 05th 2010 ] - Market Wire

ImmunoCellular Therapeutics' Clinical Data for ICT-107 To Be Featured at World Stem Cell Summit

[ Tue, Oct 05th 2010 ] - Market Wire

Human Genome Sciences Receives Complete Response .. from FDA on ZALBINa" BLA for Chronic Hepatitis C

[ Tue, Oct 05th 2010 ] - Market Wire

Enzon Announces Publication of Preclinical Study Data of PEG-SN38 in Pediatric Neuroblastoma

[ Tue, Oct 05th 2010 ] - Market Wire

Philadelphia Eagles' Offensive Lineman Todd Herre .. ical to Endorse New SPO Wellness(TM) Product Line

[ Tue, Oct 05th 2010 ] - Market Wire

Orthovita Receives FDA Clearance for VITOMATRIXa" Bone Graft Substitute in Dental Applications

Mon, October 4, 2010

[ Mon, Oct 04th 2010 ] - Market Wire

Celera Announces Resignation of Chief Financial Officer

[ Mon, Oct 04th 2010 ] - Market Wire

Alcon Names New Chief Financial Officer

[ Mon, Oct 04th 2010 ] - Market Wire

Atrium Innovations to Present at Upcoming Canaccord Genuity Healthy Living Conference

[ Mon, Oct 04th 2010 ] - Market Wire

HistoRx Recognized as a 2010 Company to Watch by the Connecticut Technology Council

[ Mon, Oct 04th 2010 ] - Market Wire

Life Technologies Completes Acquisition of Ion Torrent

[ Mon, Oct 04th 2010 ] - Market Wire

Celldex Therapeutics Presents Safety and Immunoge .. he International Society of Biological Therapy of

[ Mon, Oct 04th 2010 ] - Market Wire

Clinical Data, Inc. Launches FAMILION® Genetic T .. id in Determining the Cause of Sudden Unexplained

[ Mon, Oct 04th 2010 ] - Market Wire

Unigene Bolsters Leadership Team with Two Key Appointments

[ Mon, Oct 04th 2010 ] - Market Wire

Covidien Demonstrates Breakthroughs in Minimally .. sue Repair at 2010 American College of Surgeons C

[ Mon, Oct 04th 2010 ] - Market Wire

Elan Announces Official Launch of Manufacturing S .. d Meeting on October 5 in Paris and the Appointme

[ Mon, Oct 04th 2010 ] - Market Wire

American Anesthesiology Announces the Acquisition .. rlotte-Based Southeast Anesthesiology Consultants

[ Mon, Oct 04th 2010 ] - Market Wire

Salix Pharmaceuticals Announces Extension of XIFAXAN550 sNDA PDUFA Goal Date to March 7, 2011

Sun, October 3, 2010

[ Sun, Oct 03rd 2010 ] - Market Wire

Sanofi-aventis Commences Tender Offer to Acquire .. nding Shares of Genzyme for $69 per Share in Cash

Fri, October 1, 2010

[ Fri, Oct 01st 2010 ] - Market Wire

Medisafe 1 Technologies Successfully Tests Prototype of Patented Syringe Locking Device

[ Fri, Oct 01st 2010 ] - Market Wire

ZymoGenetics and Bristol-Myers Squibb to Present .. e 2a Interim Clinical Trial Results at AASLD 2010

[ Fri, Oct 01st 2010 ] - Market Wire

Health Management Associates, Inc. Acquires the 413-Bed Wuesthoff Health System

[ Fri, Oct 01st 2010 ] - Market Wire

OSC FINDS EUGENE MELNYK DID NOT CONTRAVENE ONTARIO SECURITIES LAW

[ Fri, Oct 01st 2010 ] - Market Wire

YM Biosciences To Present Poster On CYT387 At The .. an School Of Haematology International Conference

[ Fri, Oct 01st 2010 ] - Market Wire

Merck to Hold Third-Quarter 2010 Sales and Earnings Conference Call on Oct. 29

[ Fri, Oct 01st 2010 ] - Market Wire

Alcoa lance sa cinquime ©dition annuelle du Mois mondial de l'engagement communautaire

[ Fri, Oct 01st 2010 ] - Market Wire

Emergent BioSolutions Receives Fast Track Designa .. Monoclonal Antibody for the Treatment of Inhalati

[ Fri, Oct 01st 2010 ] - Market Wire

AVEO Pharmaceuticalsa? Tivozanib Featured at Ninth International Kidney Cancer Symposium

[ Fri, Oct 01st 2010 ] - Market Wire

DaVita Inc. Announces Offering of $1.45 Billion Senior Notes

[ Fri, Oct 01st 2010 ] - Market Wire

DaVita Inc. Commences Cash Tender Offers and Cons .. All of its 6 5/8% Senior Notes due 2013 and 7 1/

Thu, September 30, 2010

[ Thu, Sep 30th 2010 ] - Market Wire

PPD Opens Office in Novosibirsk, Russia

[ Thu, Sep 30th 2010 ] - Market Wire

WellCare to Report Third Quarter 2010 Results on November 4

[ Thu, Sep 30th 2010 ] - Market Wire

Northstar Healthcare Completes Private Placement

[ Thu, Sep 30th 2010 ] - Market Wire

CellCyte Genetics Corporation Appointments Fred Mill as Vice President of Manufacturing

[ Thu, Sep 30th 2010 ] - Market Wire

Bond Labs' NDS Expands Inventory Warehousing at Leading National Retailer

[ Thu, Sep 30th 2010 ] - Market Wire

RXi Pharmaceuticals to Webcast Presentation at the 9th Annual BIO Investor Forum

[ Thu, Sep 30th 2010 ] - Market Wire

BioSante Pharmaceuticals to Present at the Bio Investor Forum

[ Thu, Sep 30th 2010 ] - Market Wire

Abiomed Announces Specialized Partner Program for .. n the Treatment of Emergent Cardiac Care Patients

[ Thu, Sep 30th 2010 ] - Market Wire

AVEO Pharmaceuticals Regains Worldwide Rights to .. Commercialize Anti-HGF Antibody Candidate AV-299

[ Thu, Sep 30th 2010 ] - Market Wire

Teva and OncoGenex Announce Initiation of Second .. Custirsen in Men with Metastatic Prostate Cancer

[ Thu, Sep 30th 2010 ] - Market Wire

Dr. Daniel L. Farkas, Chairman and CEO of Spectra .. ed an Invited Talk at an International Scientific

Wed, September 29, 2010

[ Wed, Sep 29th 2010 ] - Market Wire

Affymax to Present at BIO Investor Forum

[ Wed, Sep 29th 2010 ] - Market Wire

ZIOPHARM Oncology to Present at the 9th Annual BIO Investor Forum

[ Wed, Sep 29th 2010 ] - Market Wire

Alnylam Publishes Results from Phase IIa Study of .. f Respiratory Syncytial Virus Infection in Lung T

[ Wed, Sep 29th 2010 ] - Market Wire

Zalicus to Present Corporate Updates in October

[ Wed, Sep 29th 2010 ] - Market Wire

Progenics Announces Approvals of New Ready-to-Use .. ed Syringes for RELISTOR in U.S., E.U. and Canada

[ Wed, Sep 29th 2010 ] - Market Wire

BD Diagnostics and Bruker Collaborate to Improve .. fication and Antimicrobial Susceptibility Testing

[ Wed, Sep 29th 2010 ] - Market Wire

Covidien plc to Report Fourth-Quarter Results on November 9, 2010

[ Wed, Sep 29th 2010 ] - Market Wire

Covidien plc presentar los resultados correspondi .. tes al cuarto trimestre el 9 de noviembre de 2010

[ Wed, Sep 29th 2010 ] - Market Wire

Quidel Announces FDA Clearance of Its QuickVue® RSV 10 Immunoassay Diagnostic Test

[ Wed, Sep 29th 2010 ] - Market Wire

Covidien plc pr©sentera ses r©sultats du quatrime trimestre le 9 novembre 2010

[ Wed, Sep 29th 2010 ] - Market Wire

Wellstar International, Inc. Announces the Result .. n of the Duke University Study Have Been Accepted

Tue, September 28, 2010

[ Tue, Sep 28th 2010 ] - Market Wire

HealthSpring, Inc. Announces the Addition of John T. Fox to Its Board of Directors

[ Tue, Sep 28th 2010 ] - Market Wire

Covidien far Apresentao na conferncia "Jefferies European Healthcare Conference"

[ Tue, Sep 28th 2010 ] - Market Wire

Amedisys Receives Civil Investigative Demand from the U.S. Department of Justice

[ Tue, Sep 28th 2010 ] - Market Wire

ARIAD to Present at the Jefferies Global SpecPharma and European Healthcare Conference

[ Tue, Sep 28th 2010 ] - Market Wire

Oncolytics Biotech Inc. Announces Issuance of Key U.S. Patent

[ Tue, Sep 28th 2010 ] - Market Wire

Covidien effectuera une pr©sentation dans le cad .. europ©enne de Jefferies sur les soins de sant©

[ Tue, Sep 28th 2010 ] - Market Wire

Presentazione di Covidien alla Jefferies European Healthcare Conference

[ Tue, Sep 28th 2010 ] - Market Wire

AVEO Pharmaceuticals, Inc. to Present at Upcoming .. cology Medical Meetings and Investment Conference

[ Tue, Sep 28th 2010 ] - Market Wire

AngioDynamics to Report Fiscal 2011 First Quarter .. sults and Hold Conference Call on October 7, 2010

[ Tue, Sep 28th 2010 ] - Market Wire

SuperGen to Present at BIO Investor Forum on October 5th

[ Tue, Sep 28th 2010 ] - Market Wire

Pieris Signs Broad Collaboration With Sanofi-Aven .. Sanofi Pasteur to Develop Anticalin Therapeutics

Mon, September 27, 2010

[ Mon, Sep 27th 2010 ] - Market Wire

Alcon Announces Third Quarter 2010 Financial Release and Conference Call Dates

[ Mon, Sep 27th 2010 ] - Market Wire

Transcend Introduces its Next Generation Platform - ENCORE

[ Mon, Sep 27th 2010 ] - Market Wire

ROBERT BURGESS APPOINTED TO IMRIS BOARD OF DIRECTORS

[ Mon, Sep 27th 2010 ] - Market Wire

Aetna Signs Contract Extension with Crozer-Keystone Health System

[ Mon, Sep 27th 2010 ] - Market Wire

ZIOPHARM Granted Japanese Patent for Darinaparsin

[ Mon, Sep 27th 2010 ] - Market Wire

Progenics Extends Agreement with Pfizer for RELISTOR Commercialization

[ Mon, Sep 27th 2010 ] - Market Wire

Media Advisory - Oncolytics Biotech(R) Inc. to Present at JMP Securities Healthcare Conference

[ Mon, Sep 27th 2010 ] - Market Wire

Emergent BioSolutions to Participate in October 2010 Investor Conferences

[ Mon, Sep 27th 2010 ] - Market Wire

Rotech Healthcare Inc. Announces Proposed Private Offering of $225 Million Senior Secured Notes

[ Mon, Sep 27th 2010 ] - Market Wire

Seattle Genetics and Millennium Announce Positive .. (SGN-35) Data from Pivotal Trial in Relapsed and

[ Mon, Sep 27th 2010 ] - Market Wire

Wellstar Announces New Website

Sun, September 26, 2010

[ Sun, Sep 26th 2010 ] - Market Wire

Aetna ©largit le spectre des Options de son Plan de sant© en Afrique

[ Sun, Sep 26th 2010 ] - Market Wire

Aetna Expands Africa Health Plan Options

Sat, September 25, 2010

[ Sat, Sep 25th 2010 ] - Market Wire

ANGIOTECH ANNOUNCES THREE YEAR DATA FROM THE HORI .. IOR OUTCOMES WITH BOSTON SCIENTIFIC CORPORATION'S

Fri, September 24, 2010

[ Fri, Sep 24th 2010 ] - Market Wire

Novartis AG, Merck KGaA, Biogen Idec, Teva and Bed Bath & Beyond

[ Fri, Sep 24th 2010 ] - Market Wire

Allergan Receives FDA Approval for OZURDEX® as T .. ious Uveitis Affecting the Posterior Segment of t

[ Fri, Sep 24th 2010 ] - Market Wire

Seattle Genetics to Host Conference Call and Webc .. arding Top-line Data from Brentuximab Vedotin (SG

[ Fri, Sep 24th 2010 ] - Market Wire

CIGNA Corporation Announces Investor Day on March 11, 2011

[ Fri, Sep 24th 2010 ] - Market Wire

Aetna Board of DirectorsDeclares Annual Cash Dividend

[ Fri, Sep 24th 2010 ] - Market Wire

SEMBIOSYS ANNOUNCES IT IS PURSUING STRATEGIC ALTERNATIVES

[ Fri, Sep 24th 2010 ] - Market Wire

Clinical Data, Inc. Presents Data from Phase I St .. ating Safety and Tolerability in Patients with As

[ Fri, Sep 24th 2010 ] - Market Wire

ArthroCare Receives FDA Clearance for Parallax Contour Vertebral Augmentation Device

[ Fri, Sep 24th 2010 ] - Market Wire

Vertex Pharmaceuticals Announces Exercise of Unde .. Additional Convertible Senior Subordinated Notes

[ Fri, Sep 24th 2010 ] - Market Wire

Celgene Corporation to Present at the JMP Securities Fifth Annual Healthcare Conference

[ Fri, Sep 24th 2010 ] - Market Wire

52-Week Phase 3 Study Found Investigational Drug .. Similar to Glipizide Plus Metformin in Improving

Thu, September 23, 2010

[ Thu, Sep 23rd 2010 ] - Market Wire

LecTec Corporation Announces Results of 2010 Shareholders Meeting

[ Thu, Sep 23rd 2010 ] - Market Wire

American CareSource To Present at the JMP Securities Healthcare Conference

[ Thu, Sep 23rd 2010 ] - Market Wire

Aetna Recognizes Six-Month Anniversary of Historic Health Care Reform Legislation

[ Thu, Sep 23rd 2010 ] - Market Wire

Tips to Help Seniors Stay Healthy for Years to Come

[ Thu, Sep 23rd 2010 ] - Market Wire

Covidien Announces Dividend Increase of 11%

[ Thu, Sep 23rd 2010 ] - Market Wire

Covidien annonce une hausse de 11 % de son dividende

[ Thu, Sep 23rd 2010 ] - Market Wire

Covidien gibt 11-prozentige Dividendenerhhung bekannt

[ Thu, Sep 23rd 2010 ] - Market Wire

ZIOPHARM Receives FDA Orphan Drug Designation for .. in in the Treatment of Peripheral T-cell Lymphoma

[ Thu, Sep 23rd 2010 ] - Market Wire

Covidien annuncia il lancio in Europa del ventilatore portatile Puritan Bennetta" 560

[ Thu, Sep 23rd 2010 ] - Market Wire

MDS Nordion to Hold Analyst Conference Call to Di .. s Signing of Framework Agreement with JSC Isotope

[ Thu, Sep 23rd 2010 ] - Market Wire

Covidien Announces the Launch of the Puritan Bennetta" 560 Portable Ventilator in Europe

Wed, September 22, 2010

[ Wed, Sep 22nd 2010 ] - Market Wire

Data Published Today Reveal That Novel Oral Thera .. Positive Response in Rheumatoid Arthritis Patient

[ Wed, Sep 22nd 2010 ] - Market Wire

Alnylam Announces Update on its Board of Directors

[ Wed, Sep 22nd 2010 ] - Market Wire

ANGIOTECH ANNOUNCES LONG-TERM DATA SHOW ADVANTAGE .. É(R) STENT IN SMALL VESSELS AND LONG LESIONS

[ Wed, Sep 22nd 2010 ] - Market Wire

Cardiovascular Systems Reports Results from Three .. eripheral Clinical Studies at TCT on September 22

[ Wed, Sep 22nd 2010 ] - Market Wire

ACADIA Pharmaceuticals to Present at the Fifth An .. ities Healthcare Conference on September 28, 2010

[ Wed, Sep 22nd 2010 ] - Market Wire

Health Net Again Named to Hispanic Business Magazinea?s Diversity Elite Top 60

[ Wed, Sep 22nd 2010 ] - Market Wire

BioSante Pharmaceuticals, Inc. To Present at the JMP Healthcare Conference

[ Wed, Sep 22nd 2010 ] - Market Wire

Medtronica?s Resolute Drug-Eluting Stent Shows Strong Performance in Second aAll Comersa? Study

[ Wed, Sep 22nd 2010 ] - Market Wire

Valeant and Biovail Announce Valeanta?s Intention .. d to Valeant Stockholders upon Obtaining Sharehol

[ Wed, Sep 22nd 2010 ] - Market Wire

Aeterna Zentaris to Present at Upcoming Sachs 10t .. l Biotech Europe Investment Forum on September 29

[ Wed, Sep 22nd 2010 ] - Market Wire

Zalicus to Present at the Fifth Annual JMP Securities Healthcare Conference

Tue, September 21, 2010

[ Tue, Sep 21st 2010 ] - Market Wire

Law Office of Brodsky & Smith, LLC Announces Investigation of Otix Global, Inc.

[ Tue, Sep 21st 2010 ] - Market Wire

St. Jude Medical anuncia aprobacin europea de pro .. Athena para la gestin de tratamientos de estimula

[ Tue, Sep 21st 2010 ] - Market Wire

Progenics Announces Clinical Completion of Subcut .. fety Study in Chronic Non-Malignant Pain Patients

[ Tue, Sep 21st 2010 ] - Market Wire

Roche's E-Plate VIEW Joins Impedance-based Real-time Monitoring with Visual Inspection of Cells

[ Tue, Sep 21st 2010 ] - Market Wire

Clinical Data, Inc. to Present at the JMP Securities Healthcare Conference

[ Tue, Sep 21st 2010 ] - Market Wire

Exact Sciences to Present at JMP Securities Healthcare Conference

[ Tue, Sep 21st 2010 ] - Market Wire

Salix Pharmaceuticals to Present at JMP Conference

[ Tue, Sep 21st 2010 ] - Market Wire

Celera Announces Issuance of United States Patent .. nt as a Predictor of Increased Risk of Myocardial

[ Tue, Sep 21st 2010 ] - Market Wire

ImmunoGen, Inc. Announces Start of SAR566658 Clinical Testing

[ Tue, Sep 21st 2010 ] - Market Wire

Cardiac Science Launches Cambridge Hearta?s Micro .. lternans (MTWA) Technology in Stress Test Systems

[ Tue, Sep 21st 2010 ] - Market Wire

DaVita Announces Refinancing of Existing Indebtedness and Estimate of Third Quarter Earnings

Mon, September 20, 2010

[ Mon, Sep 20th 2010 ] - Market Wire

CompCare Retains KCSA Strategic Communications for Investor Relations

[ Mon, Sep 20th 2010 ] - Market Wire

Annals of Thoracic Surgery Publishes U.S. Registr .. ts for Abiomed AB5000a" Ventricular Assist Device

[ Mon, Sep 20th 2010 ] - Market Wire

ZIOPHARM Oncology to Present at the JMP Healthcare Conference

[ Mon, Sep 20th 2010 ] - Market Wire

Health Net Selected as a Top Military Spouse Friendly Employer

[ Mon, Sep 20th 2010 ] - Market Wire

Celldex Therapeutics Announces Initiation of Rand .. inical Trial of CDX-011 in Advanced Breast Cancer

[ Mon, Sep 20th 2010 ] - Market Wire

St. Jude Medical gibt europische Zulassung des At .. en Generation zum Management von Tiefenhirnstimul

[ Mon, Sep 20th 2010 ] - Market Wire

Micromet Initiates Phase 2 Trial of Blinatumomab .. Relapsed/Refractory Acute Lymphoblastic Leukemia

[ Mon, Sep 20th 2010 ] - Market Wire

Micromet Initiates European Pivotal Trial of Blin .. Adult Patients with Acute Lymphoblastic Leukemia

[ Mon, Sep 20th 2010 ] - Market Wire

Celera Signs Agreement with Abbott for Distributi .. Identify Patients at Risk of Coronary Heart Disea

[ Mon, Sep 20th 2010 ] - Market Wire

Prestige Brands Holdings, Inc. Announces Agreement to Acquire Blacksmith Brands

[ Mon, Sep 20th 2010 ] - Market Wire

24-Week Phase 3 Study Found Investigational Drug .. ylated Hemoglobin (HbA1c) When Added to Glimepiri

Fri, September 17, 2010

[ Fri, Sep 17th 2010 ] - Market Wire

UnitedHealth Group, Humana, HealthSpring and Universal American

[ Fri, Sep 17th 2010 ] - Market Wire

Ramius Sends Letter to Independent Board Members of Cypress

[ Fri, Sep 17th 2010 ] - Market Wire

Medtronic Showcases Cardiovascular Devices at TCT 2010

[ Fri, Sep 17th 2010 ] - Market Wire

Emergent BioSolutions Awarded HHS Contract Valued .. to $186.6 Million to Develop rPA Anthrax Vaccine

[ Fri, Sep 17th 2010 ] - Market Wire

Newly Published Data Show Occipital Nerve Stimula .. y Be a Promising New Therapy for Chronic Migraine

[ Fri, Sep 17th 2010 ] - Market Wire

CytoGenix, Inc. Initiates Ferret Testing Expecting Positive Results for Avian Flu Vaccine Study

[ Fri, Sep 17th 2010 ] - Market Wire

AUSTRALIA';S CANBERRA HOSPITAL UNVEILS IMRISneuro SUITE

[ Fri, Sep 17th 2010 ] - Market Wire

Health Net Sponsors the 3rd National Veterans Summer Sports Clinic in San Diego

[ Fri, Sep 17th 2010 ] - Market Wire

Ligand Enters into Agreement with Proximagen for CXCR4 Target

[ Fri, Sep 17th 2010 ] - Market Wire

Response Genetics, Inc. Settles Proxy Contest With Special Situations Fund

[ Fri, Sep 17th 2010 ] - Market Wire

Data to Be Presented at ERS Conference Highlights .. enefit Cystic Fibrosis Patients on Minimal Pharma

Thu, September 16, 2010

[ Thu, Sep 16th 2010 ] - Market Wire

Community Health Systems Announces New 4 Million Share Open Market Share Repurchase

[ Thu, Sep 16th 2010 ] - Market Wire

Abiomed Showcases Impella® Technology at TCT 201 .. eakfast Series Featuring USpella and Case Reviews

[ Thu, Sep 16th 2010 ] - Market Wire

Healthways Announces Achievements in Medicare Health Support; Other Seniorsa? Programs

[ Thu, Sep 16th 2010 ] - Market Wire

Medtronic Receives European CE Mark Approval for .. Brain Stimulation Therapy for Refractory Epilepsy

[ Thu, Sep 16th 2010 ] - Market Wire

Cellular Dynamics International, ACEA Biosciences .. Cooperate to Evaluate iCell Cardiomyocytes on the

[ Thu, Sep 16th 2010 ] - Market Wire

NPS Pharmaceuticals Announces Pricing of Public Offering of Common Stock

[ Thu, Sep 16th 2010 ] - Market Wire

ImmunoCellular Therapeutics Selects Averion Inter .. onal Corp. to Conduct Phase II Glioblastoma Study

[ Thu, Sep 16th 2010 ] - Market Wire

Akorn Announces Launch of Erythromycin Ophthalmic Ointment USP 1 g

[ Thu, Sep 16th 2010 ] - Market Wire

GTx Announces Corporate Presentation at the UBS Global Life Sciences Conference

[ Thu, Sep 16th 2010 ] - Market Wire

Alkermes Stock Trading Halted Today

[ Thu, Sep 16th 2010 ] - Market Wire

BioCryst Reports Positive Results From A Phase 2 .. 8 Combined with Allopurinol in Patients with Gout

Wed, September 15, 2010

[ Wed, Sep 15th 2010 ] - Market Wire

Gileads HIV-Einzeltablette, das aQuada-Prparat, z .. 8-wchiger Phase-II-Studie hohe virale Suppression

[ Wed, Sep 15th 2010 ] - Market Wire

LecTec Corporation Announces Director Plans to Retire

[ Wed, Sep 15th 2010 ] - Market Wire

Covidien maakt hoogtepunten beleggersvergadering bekend

[ Wed, Sep 15th 2010 ] - Market Wire

PPD Named to InformationWeek 500 List of Top Technology Innovators

[ Wed, Sep 15th 2010 ] - Market Wire

Phase I/II Data Published in New England Journal .. Incyte JAK Inhibitor, INCB18424, Provides Marked

[ Wed, Sep 15th 2010 ] - Market Wire

Qtrax Beta Available in India

[ Wed, Sep 15th 2010 ] - Market Wire

Baxter International Third Quarter 2010 Financial Results Conference Call

[ Wed, Sep 15th 2010 ] - Market Wire

Covidien Anuncia Destaques da Assembl©ia de Investidores

[ Wed, Sep 15th 2010 ] - Market Wire

Covidien anuncia los temas ms importantes tratados en la reunin de inversores

[ Wed, Sep 15th 2010 ] - Market Wire

Covidien comunica i punti salienti emersi nel corso dell'assemblea degli investitori

[ Wed, Sep 15th 2010 ] - Market Wire

Covidien gibt Hhepunkte seiner Investorenversammlung bekannt

AVEO Pharmaceuticals, Inc. to Present at Upcoming Oncology Medical Meetings and Investment Conference

_{//health-fitness.news-articles.net/content/2010/ .. -medical-meetings-and-investment-conference.html}
^{Published in Health and Fitness on Tuesday, September 28th 2010 at 3:40 GMT by Market Wire}

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that the company will have a presence at two upcoming oncology medical meetings and Citia�s 5^th Annual Biotech Day investment conference.

"Hidden Gems in Hematology/Oncology: A Survey of What to Keep an Eye on"

Data from AVEOa�s tivozanib clinical development program will be presented at the following medical meetings:

9^th International Kidney Cancer Symposium (IKCS), October 1-2, 2010 at the Swiss'tel in Chicago.
35^th European Society for Medical Oncology (ESMO) Congress, October 8-12, 2010 in Milan, Italy.

In addition, William Slichenmyer, M.D., Sc.M., chief medical officer of AVEO, is scheduled to be featured on the panel, aHidden Gems in Hematology/Oncology: A Survey of What to Keep an Eye on,a on Tuesday, October 5, 2010 at 3:00 p.m. EDT as part of Citia�s 5^th Annual Biotech Day investment conference at the Westin Waterfront Hotel in Boston.

About AVEO

AVEO Pharmaceuticals (NASDAQ: AVEO) integrates a proprietary cancer biology platform with drug development and commercial expertise in its efforts to discover and develop targeted cancer therapeutics. The companya�s lead product, tivozanib, is an oral, triple VEGF receptor inhibitor with a highly differentiated profile. Tivozanib is currently being investigated in a global, randomized Phase 3 clinical trial called TIVO-1 comparing tivozanib to sorafenib in advanced kidney cancer, as well as additional clinical studies in other solid tumor types. AVEOa�s proprietary, integrated cancer biology platform offers the company a unique advantage in oncology drug development and has provided a discovery engine for high-value targets. This approach has resulted in a promising pipeline of monoclonal antibodies against novel targets includingHGF, ErbB3, RON, Notch andFGFR. For more information, please visit the company's website at [ www.aveopharma.com ].

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire